Artículos por temáticas
En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.
Tema
Enfermedad de Parkinson
2030 ARTíCULOS , VIENDO DEL 91 AL 105
Personalizing Parkinson's disease through the journey of Michael J. Fox.
Huse J.
J Nurs Educ. 2010 Dec;49(12):719. doi: 10.3928/01484834-20101117-03. No abstract available.
0
0
0
Ophthalmological and electrophysiological features of Parkinson's disease.
Nowacka B, Lubiński W, Karczewicz D.
Klin Oczna. 2010;112(7-9):247-52. Review.
0
0
0
Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT Jr; American Academy of Neurology Parkinson Disease Measure Development Panel..
Neurology. 2010 Nov 30;75(22):2021-7. doi: 10.1212/WNL.0b013e3181ff96dd.
0
0
0
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.
Mortiboys H, Johansen KK, Aasly JO, Bandmann O.
Neurology. 2010 Nov 30;75(22):2017-20. doi: 10.1212/WNL.0b013e3181ff9685.
0
0
0
Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.
Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH.
Neurology. 2010 Nov 30;75(22):2009-16. doi: 10.1212/WNL.0b013e3181ff96bf.
0
0
0
CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes.
Schiess MC, Barnes JL, Ellmore TM, Poindexter BJ, Dinh K, Bick RJ.
BMC Neurosci. 2010 Nov 29;11:151. doi: 10.1186/1471-2202-11-151.
0
0
0
Hu GX, Qian ZY, Sun T, Yang TM, Wang WH.
Guang Pu Xue Yu Guang Pu Fen Xi. 2010 Sep;30(9):2360-4. Chinese.
0
0
0
Discovering neuroprotection in Parkinson's disease, or getting to haphazard.
Kieburtz K.
Mt Sinai J Med. 2010 Nov-Dec;77(6):700-6. doi: 10.1002/msj.20219.
0
0
0
Active theater as a complementary therapy for Parkinson's disease rehabilitation: a pilot study.
Modugno N, Iaconelli S, Fiorlli M, Lena F, Kusch I, Mirabella G.
ScientificWorldJournal. 2010 Nov 16;10:2301-13. doi: 10.1100/tsw.2010.221.
0
0
0
Labudda K, Brand M, Mertens M, Ollech I, Markowitsch HJ, Woermann FG.
Behav Neurol. 2010;23(3):131-43. doi: 10.3233/BEN-2010-0277.
0
0
0
Schwarzschild MA.
Neurology. 2010 Nov 23;75(21):1943-4; author reply 1944-5. doi: 10.1212/WNL.0b013e3181fac7f9. No abstract available.
0
0
0
Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial.
Troche MS, Okun MS, Rosenbek JC, Musson N, Fernandez HH, Rodriguez R, Romrell J, Pitts T, Wheeler-Hegland KM, Sapienza CM.
Neurology. 2010 Nov 23;75(21):1912-9. doi: 10.1212/WNL.0b013e3181fef115.
0
0
0
Challenges of medication management in hospitalized patients with Parkinson's disease.
Wood LD, Neumiller JJ, Carlson J, Setter SM, Corbett CF.
Am J Health Syst Pharm. 2010 Dec 1;67(23):2059-63. doi: 10.2146/ajhp100170. No abstract available.
0
0
0
Towards high accuracy classification of MER signals for target localization in Parkinson's disease.
Pinzon-Morales RD, Orozco-Gutierrez AA, Carmona-Villada H, Castellanos CG.
Conf Proc IEEE Eng Med Biol Soc. 2010;2010:4040-3. doi: 10.1109/IEMBS.2010.5628014.
0
0
0
Tien I, Glaser SD, Aminoff MJ.
Conf Proc IEEE Eng Med Biol Soc. 2010;2010:3353-6. doi: 10.1109/IEMBS.2010.5627904.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
